Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Weiss

Showing results (121-130 of 199) with videos related to

Pageof 20
Sort By:
Plos One|July 29, 2024
Prognostic potential of integrated morphologic and metabolic parameters of pre-therapeutic [18F]FDG-PET/CT regarding progression-free survival (PFS) and overall survival (OS) in NSCLC-patientsHelena A Peters, Daniel Weiss, Matthias Boschheidgen, et al.
Pathogens (Basel, Switzerland)|December 22, 2023
The Impact of <i>Pseudomonas aeruginosa</i> Infection in Adult Cystic Fibrosis Patients-A Single Polish Centre StudySylwia Jarzynka, Oliwia Makarewicz, Daniel Weiss, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 17, 2016
Alpha-synuclein gene variants may predict neurostimulation outcomeDaniel Weiss, Sonja Herrmann, Lisa Wang, et al.
Clinical Neuroradiology|January 14, 2025
Deep-Learning-based Automated Identification of Ventriculoperitoneal-Shunt Valve Models from Skull X-raysMarius Vach, Daniel Weiss, Vivien Lorena Ivan, et al.
The European Journal of Neuroscience|March 8, 2012
Subthalamic nucleus stimulation restores the efferent cortical drive to muscle in parallel to functional motor improvementDaniel Weiss, Sorin Breit, Julia Hoppe, et al.
The International Journal of Neuropsychopharmacology|August 14, 2008
Sustained improvement of obsessive-compulsive disorder by deep brain stimulation in a woman with residual schizophreniaChristian Plewnia, Franziska Schober, Albrecht Rilk, et al.
Cancer Chemotherapy and Pharmacology|March 25, 2014
No clinically significant drug interactions between lenalidomide and P‑glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteersNianhang Chen, Daniel Weiss, Josephine Reyes, et al.
Neurological Research|December 8, 2022
Mothership vs. drip-and-ship: evaluation of initial treatment strategies for acute ischemic stroke in a well-developed network of specialized hospitalsDaniel Weiss, Christian Rubbert, Marius Kaschner, et al.
Parkinsonism & Related Disorders|July 18, 2021
Telemedicine and Deep brain stimulation - Current practices and recommendationsVibhash D Sharma, Delaram Safarpour, Shyamal H Mehta, et al.
Neuromodulation : Journal of the International Neuromodulation Society|March 1, 2022
Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain StimulationAgnes Langer, Lara Lucke-Paulig, Lucia Gassner, et al.
Pageof 20

Showing results (121-130 of 199) with videos related to

Sort By:
Pageof 20
Plos One|July 29, 2024
Prognostic potential of integrated morphologic and metabolic parameters of pre-therapeutic [18F]FDG-PET/CT regarding progression-free survival (PFS) and overall survival (OS) in NSCLC-patientsHelena A Peters, Daniel Weiss, Matthias Boschheidgen, et al.
Pathogens (Basel, Switzerland)|December 22, 2023
The Impact of <i>Pseudomonas aeruginosa</i> Infection in Adult Cystic Fibrosis Patients-A Single Polish Centre StudySylwia Jarzynka, Oliwia Makarewicz, Daniel Weiss, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 17, 2016
Alpha-synuclein gene variants may predict neurostimulation outcomeDaniel Weiss, Sonja Herrmann, Lisa Wang, et al.
Clinical Neuroradiology|January 14, 2025
Deep-Learning-based Automated Identification of Ventriculoperitoneal-Shunt Valve Models from Skull X-raysMarius Vach, Daniel Weiss, Vivien Lorena Ivan, et al.
The European Journal of Neuroscience|March 8, 2012
Subthalamic nucleus stimulation restores the efferent cortical drive to muscle in parallel to functional motor improvementDaniel Weiss, Sorin Breit, Julia Hoppe, et al.
The International Journal of Neuropsychopharmacology|August 14, 2008
Sustained improvement of obsessive-compulsive disorder by deep brain stimulation in a woman with residual schizophreniaChristian Plewnia, Franziska Schober, Albrecht Rilk, et al.
Cancer Chemotherapy and Pharmacology|March 25, 2014
No clinically significant drug interactions between lenalidomide and P‑glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteersNianhang Chen, Daniel Weiss, Josephine Reyes, et al.
Neurological Research|December 8, 2022
Mothership vs. drip-and-ship: evaluation of initial treatment strategies for acute ischemic stroke in a well-developed network of specialized hospitalsDaniel Weiss, Christian Rubbert, Marius Kaschner, et al.
Parkinsonism & Related Disorders|July 18, 2021
Telemedicine and Deep brain stimulation - Current practices and recommendationsVibhash D Sharma, Delaram Safarpour, Shyamal H Mehta, et al.
Neuromodulation : Journal of the International Neuromodulation Society|March 1, 2022
Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain StimulationAgnes Langer, Lara Lucke-Paulig, Lucia Gassner, et al.
Pageof 20